Skip to main content

What the FDA labels say about taking them together

Maribavir and valganciclovir

Maribavir's FDA label of January 27, 2026 names valganciclovir in its drug interactions section; the valganciclovir label PlainMeds reads does not name maribavir. The maribavir label: “Coadministered with Ganciclovir or Valganciclovir LIVTENCITY is not recommended to be coadministered with valganciclovir/ganciclovir (vGCV/GCV).”

Check it at the source: the maribavir FDA label on DailyMed (effective January 27, 2026, Takeda Pharmaceuticals America, Inc.); the valganciclovir FDA label on DailyMed (effective December 8, 2025, H2-Pharma, LLC).

What does the maribavir label say about valganciclovir?

Maribavir label, drug interactions

Coadministered with Ganciclovir or Valganciclovir LIVTENCITY is not recommended to be coadministered with valganciclovir/ganciclovir (vGCV/GCV).

Maribavir label, warnings and precautions

WARNINGS AND PRECAUTIONS LIVTENCITY may antagonize the antiviral activity of ganciclovir and valganciclovir.

Source: FDA drug label (Livtencity), Takeda Pharmaceuticals America, Inc., effective January 27, 2026 (SPL set c94fc2c5-e840-4f18-b7d8-d5eacb26d3a0), via openFDA; the full label on DailyMed

What does the valganciclovir label say about maribavir?

Valganciclovir's label (effective December 8, 2025) does not name maribavir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Valcyte), NDA021304 (Cheplapharm), as published by H2-Pharma, LLC, effective December 8, 2025 (SPL set 4c517a39-2ded-4c5a-8d56-276853414b31), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Maribavir generic labelers
19Valganciclovir generic labelers
MaribavirValganciclovir
Labeled forn/an/a
Boxed warningNoYes
Pharmacy cost (NADAC)n/a$1.91 per tablet 450 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?